Distinct functional motifs within the IL-17 receptor regulate signal transduction and target gene expression
- Amarnath Maitra†,
- Fang Shen†,
- Walter Hanel†,
- Karen Mossman‡,
- Joel Tocker§,
- David Swart§, and
- Sarah L. Gaffen†,¶,‖
- Departments of †Oral Biology and
- ¶Microbiology and Immunology, University at Buffalo, State University of New York, Buffalo, NY 14214;
- §Department of Inflammation Research, Amgen, Inc., Seattle, WA 98119; and
- ‡Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada L8N 3Z5
-
Edited by Laurie H. Glimcher, Harvard Medical School, Boston, MA, and approved March 19, 2007 (received for review December 27, 2006)
Abstract
IL-17 is the founding member of a novel family of proinflammatory cytokines that defines a new class of CD4+ effector T cells, termed “Th17.” Mounting evidence suggests that IL-17 and Th17 cells cause pathology in autoimmunity, but little is known about mechanisms of IL-17RA signaling. IL-17 through its receptor (IL-17RA) activates genes typical of innate immune cytokines, such as TNFα and IL-1β, despite minimal sequence similarity in their respective receptors. A previous bioinformatics study predicted a subdomain in IL-17-family receptors with homology to a Toll/IL-1R (TIR) domain, termed the “SEFIR domain.” However, the SEFIR domain lacks motifs critical for bona fide TIR domains, and its functionality was never verified. Here, we used a reconstitution system in IL-17RA-null fibroblasts to map functional domains within IL-17RA. We demonstrate that the SEFIR domain mediates IL-17RA signaling independently of classic TIR adaptors, such as MyD88 and TRIF. Moreover, we identified a previously undescribed“TIR-like loop” (TILL) required for activation of NF-κB, MAPK, and up-regulation of C/EBPβ and C/EBPδ. Mutagenesis of the TILL domain revealed a site analogous to the LPSd mutation in TLR4, which renders mice insensitive to LPS. However, a putative salt bridge typically found in TIR domains appears to be dispensable. We further identified a C-terminal domain required for activation of C/EBPβ and induction of a subset IL-17 target genes. This structure-function analysis of a IL-17 superfamily receptor reveals important differences in IL-17RA compared with IL-1/TLR receptors.
Footnotes
- ‖To whom correspondence should be addressed. E-mail: sgaffen{at}buffalo.edu
-
Author contributions: A.M., F.S., and W.H. contributed equally to this work; A.M., F.S., W.H., and S.L.G. designed research; A.M., F.S., W.H., and S.L.G. performed research; A.M., F.S., and W.H. analyzed data; K.M., J.T., and D.S. contributed new reagents/analytic tools; and S.L.G. wrote the paper.
-
Conflict of interest statement: J.T. and D.S. own stock in Amgen.
-
This article is a PNAS Direct Submission.
-
This article contains supporting information online at www.pnas.org/cgi/content/full/0611589104/DC1.
- Abbreviations:
- C/EBP,
- CCAAT/Enhancer binding protein;
- FL,
- full length;
- RA,
- rheumatoid arthritis;
- SEFIR,
- SEF/IL-17R domain;
- TILL,
- TIR-like loop;
- TIR,
- Toll/IL-1 receptor domain.
- © 2007 by The National Academy of Sciences of the USA





